CD4+ T-cell receptor complex (TCR complex)

The CD4+ T-cell receptor (TCR) complex is a sophisticated multi-subunit transmembrane signaling apparatus located on the surface of helper T cells. It is primarily composed of a variable antigen-binding heterodimer, typically consisting of alpha and beta chains, which is non-covalently associated with invariant CD3 signaling subunits (gamma, delta, epsilon, and zeta chains) (Source: UniProt, P04234). This complex is specialized to recognize processed peptide antigens presented by Major Histocompatibility Complex (MHC) Class II molecules, which are predominantly expressed on professional antigen-presenting cells like dendritic cells (Source: Janeway's Immunobiology, 9th Ed). In oncology, the CD4+ TCR complex is a critical focus for immunotherapy, as CD4+ T cells play a vital role in orchestrating the anti-tumor immune response by secreting pro-inflammatory cytokines and supporting the activity of CD8+ cytotoxic T cells (Source: PubMed, PMID: 30104475). Therapeutic interventions often involve engineering T cells with high-affinity TCRs (TCR-T therapy) or using bispecific molecules to redirect T-cell specificity toward tumor-specific MHC-peptide complexes (Source: Journal of Clinical Investigation, 2019). While highly effective, targeting this complex requires precise HLA matching and carries risks of systemic inflammatory toxicities such as cytokine release syndrome (Source: NIH, National Cancer Institute).

Other names

T-cell receptor-CD3 complexTCR-CD3 complexMHC class II-restricted T-cell receptorCD4-TCR complexAntigen receptor complex

Antigen-specific T-cell activation, Cytokine-mediated anti-tumor response, Orchestration of adaptive immunity, Direct T-cell mediated cytotoxicity